Ibuproxam

This classification denotes a nonsteroidal antiinflammatory drug with the molecular formula C13H19NO2, a preparation that US FDA regulates as an active ingredient or moiety under Unique Ingredient Identifier O3LD16O96Z, chemically known as propionohydroxamic acid, 2-(p-isobutylphenyl)-, d,l- but generally known as ibuproxam, which bears US NIH Compound Identifier 68704. European Medicines Agency schedules Ibuproxam in its eXtended EudraVigilance Medicinal Product Dictionary or XEVMPD under Index SUB08099MIG. The term IBUPROXAM is an International Non-Proprietary Name or INN (see WHO INN reference publication, Volume 30, No. 10 1976, List 16). World Health Organization schedules ibuproxam in its Anatomical Therapeutic Chemical (ATC) Classification. IBUPROXAM is scheduled in the U.S. International Trade Commission's Harmonized Tariff System (HTS) Pharmaceutical Appendix. Most nations schedule ibuproxam under HS 29280090 and SITC 51486. As of Q4 2014, IBUPROXAM remains the US FDA Preferred Term for this commodity. Ibuproxam bears US NLM identifiers UMLS ID C0063268 and NCI Concept Code C83774. SMILES: O=C(NO)C(C1CCC(CC(C)C)CC1)C.